Kalil Abdullah
Neurological Surgery · Dallas, TXNPI 1073892758
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,720 of the $3,959 with a category attached, or 68.7%. Medexus Pharma, Inc. accounts for 72.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $2,983 and has fallen 92.3% since, to $230 in 2025. That places this record below the midpoint for neurological surgery clinicians in TX, where the typical reported total is $3,746.
Across 18 payments — averaging $219.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medexus Pharma, Inc.$3K
- Monteris Medical Corporation$464
- Zap Surgical Systems, Inc.$283
- Stryker$108
- Viseon, Inc.$103
- NX Development Corp.$78
- plus $73 from 3 others
Across 9 payments — averaging $5084.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Monteris Medical Corporation$46K
What the payments were for
- Consulting fees$2,72069%
- Travel & lodging$351%
- Food & beverage$1,20430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medexus Pharma, Inc. | 2 | $2,849 |
| Monteris Medical Corporation | 5 | $464 |
| Zap Surgical Systems, Inc. | 1 | $283 |
| Stryker | 5 | $108 |
| Viseon, Inc. | 1 | $103 |
| NX Development Corp. | 1 | $78 |
| Medtronic | 1 | $35 |
| Integra Lifesciences Corporation | 1 | $19 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,959 in reported general payments places this provider in the 50th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 27 | $421 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Dallas
- Richard MeyratDallas$883K
- Bartley MitchellDallas$255K
- Jeremy DenningDallas$204K
- Randall GrahamDallas$138K
- Babu WelchDallas$123K
- Stephen KatzenDallas$115K
- Michael OhDallas$111K
- Bala GiriDallas$101K
- Koijan KainthThe Woodlands$1.3M
- Luis DuarteSan Angelo$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.